You are here

P&T July 2013

Features

Federal Office in Charge of Drug Discounts Begins to Feel the Heat
Upselling takes place when a safety-net hospital increases its profits by selling discounted drugs to privately insured patients at full price. Senator Charles Grassley is on the case to increase transparency and to curtail the misuse of 340B purchases.
Health Care & Law
Drugs in short supply, especially those needed in oncology, can create legal and patient-safety problems for risk-bearing providers.
Meeting Highlights
Therapies for pancreatic, breast, lung, and skin cancers were some of the hot topics at this year’s ASCO meeting.
Meeting Highlights
2013 52nd Annual Assembly: Medication Safety
The Emily Jerry Foundation was instrumental in requiring training and certification for pharmacy technicians; and a representative from the institute for Safe Medication Practices discusses “off-the-beaten-track” areas of medication use.

Departments

Medication Errors
Preventing acute hyponatremia in hospitalized children
Prescription: Washington
Congress finally addresses track-and-trace technology.

FDA approvals, drug indications, and updates

Fluticasone furoate/vilanterol inhalation powder (Breo Ellipta) for chronic obstructive pulmonary disease; atorvastatin/ezetimibe tablets (Liptruzet) for reducing low-density lipoproteincholesterol; and radium 223 dichloride (Xofigo) injection for late-stage, castrationresistant prostate cancer

Drug Forecast
Aclidinium bromide inhalation powder (Tudorza) for COPD